Concepedia

David G. McLaren

DG

Statistics

Publications

55

Citations

3K

H-Index

26

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Genus (United States)

Netherlands Metabolomics Centre

Leiden University

University of Edinburgh

David G. McLaren is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and pharmacology.

Top concepts

Publications per year

1991–2024

55

Publications

55

Targeting a ceramide double bond improves insulin resistance and hepatic steatosis

Bhagirath Chaurasia, Trevor S. Tippetts, Rafael Mayoral et al. · Science · 2019 · 432 citations · Full text

Use of the CRISPR/Cas9 System to Produce Genetically Engineered Pigs from In Vitro-Derived Oocytes and Embryos1

Kristin M. Whitworth, Kiho Lee, Joshua A. Benne et al. · Biology of Reproduction · 2014 · 348 citations · Full text

, , +16

Genome edited sheep and cattle

Chris Proudfoot, Daniel F. Carlson, Rachel Huddart et al. · Transgenic Research · 2014 · 272 citations · Full text

, , +18

Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia

Yin Wu, Ester Carballo‐Jane, David G. McLaren et al. · Journal of Lipid Research · 2011 · 210 citations · Full text

Live pigs produced from genome edited zygotes

Simon Lillico, Chris Proudfoot, Daniel F. Carlson et al. · Scientific Reports · 2013 · 177 citations · Full text

1–5 of 55